Biotech Insight Management has changed its name to Axion Capital Management

Axion Capital Management is a boutique investment advisory firm specializing in both public and private opportunities for qualified investors. Our recent name change coincides with the fund's strategic shift beyond the narrow biotech and life sciences space and toward a more expansive opportunistic strategy.

Our flagship Axion Opportunity Fund is an equity long / short absolute return fund. The Fund's more expansive investment universe allows us to draw upon nearly four decades of experience in energy, base materials, commodities, emerging markets and technology sectors.

Axion Capital Management also maintains a portfolio of private companies, including AmpliMed Corporation, a clinical-stage cancer pharmaceutical company founded by world-renowned oncologists.

Please feel free to contact if you have any questions

Joel Smolen
General Partner / Managing Director

Axion Capital Management, L.L.C.
Axion Opportunity Fund, L.P.
131 Baypoint Drive
San Rafael, CA
94901

Tel. 415.785.7121
Fax 415.256.9843